Therapeutic Plasma Exchange in Septic Shock: A Pilot Study

Recruiting Phase 2 Interventional Study
Septic Shock
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
16 and older
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
80 (estimated)
Sponsor
University of Manitoba · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The investigators propose to conduct a multi-center randomized pilot feasibility trial comparing therapeutic plasma exchange to standard of care in patients diagnosed with septic shock.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Eligible patients must be admitted to an ICU and must meet all of the following inclusion criteria: 1. ≥ 16 years of age 2. Refractory hypotension documented within 48 hours prior to enrollment requiring the institution and ongoing use of vasopressor agents (phenylephrine, norepinephrine, vasopress…
Contacts

Emily Rimmer, MD, MSc

204-787-2128

erimmer@cancercare.mb.ca

CONTACT

Chantale Pineau, BA

204-235-3223

chantale.pineau@umanitoba.ca

CONTACT